FDA flags high-risk recall of Insulet's Omnipod 5 pods over insulin delivery concerns

The U.S. Food and Drug Administration (FDA) has classified a recall of Insulet Corporation's PODD Omnipod 5 Pods as its most ...
Drug Delivery Business

FDA says Insulet Omnipod 5 recall is serious after 476 device reports, issue is potentially undetectable by user

The Omnipod 5 [Image courtesy of Insulet]The FDA says last month’s recall of Insulet (Nasdaq:PODD) Omnipod 5 insulin pump ...

How The Insulet (PODD) Narrative Is Shifting After Omnipod 5 Correction And Repriced Expectations

Insulet’s modeled fair value has been trimmed slightly from US$340.26 to US$326.35, indicating a more conservative price target in the updated analysis. This adjustment aligns with the mixed analyst ...
Seeking Alpha

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

OAKVILLE, ON, April 7, 2025 /CNW/ - Insulet Corporation (PODD), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that Omnipod 5 is now ...
Morningstar

Insulet Hits Omnipod 5 Out of the Park; Raising Our Fair Value Estimate

The user-friendly Omnipod has been particularly successful among children and teens. After a major management changeover in 2014-15, Insulet has improved its manufacturing and commercialization ...

Insulet to Participate in BofA Securities 2026 Health Care Conference

Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products ...